It has only been in the last decade that the medical and scientific industries have undergone a transition from analog to digital processes, at great benefit to the field of diagnostics and pathology.

Radical improvements to digital pathology equipment have occurred, including the digitisation of slide images and advancements in the handling, analysing and storing of large amounts of data. These developments have led to greater automation, increasing clinical efficiency and accuracy, and reduced pathology costs.


Today, digital pathology is an essential tool that assists with increasing our knowledge of disease and improving the way we treat and diagnose it. As a result, the demand for better and faster diagnostic tools for both human and animal diseases are on the rise, as is the need to improve workflow efficiency, minimise human error and reduce the costliness of conventional diagnostics.

With the incorporation of Artificial Intelligence into digital pathology, as we have done here at Telenostic with our digital parasitology technology OvaCyte™, the limits of pathology studies and data management have been further expanded. This combination of digital pathology including state-of-the-art software and hardware, Artifical Intelligence and cloud services improves connectivity, accuracy and precision, which in turn allows for the automation of pathological processes. This results in decreased turnaround times to results and the improvement of patient outcomes due to improved targeted treatment.